• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular analysis of leukemias with chromosomal translocation and its application for clinical Diagnosis

Research Project

Project/Area Number 05454328
Research Category

Grant-in-Aid for General Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field Hematology
Research InstitutionUniversity of Tokyo

Principal Investigator

HIRAI Hisamaru  University of Tokyo, Department of Internal Medicine, Associate Professor, 医学部(病), 講師 (90181130)

Co-Investigator(Kenkyū-buntansha) TANAKA Tomoyuki  University of Tokyo, Department of Internal Medicine, Assistant Professor, 医学部(病), 助手 (50227154)
HANAZONO Yutaka  University of Tokyo, Department of Internal Medicine, Assistant Professor, 医学部(病), 助手 (70251246)
MITANI Kinuko  University of Tokyo, Department of Internal Medicine, Assistant Professor, 医学部(病), 助手 (50251244)
Project Period (FY) 1993 – 1994
Project Status Completed (Fiscal Year 1994)
Budget Amount *help
¥6,400,000 (Direct Cost: ¥6,400,000)
Fiscal Year 1994: ¥2,700,000 (Direct Cost: ¥2,700,000)
Fiscal Year 1993: ¥3,700,000 (Direct Cost: ¥3,700,000)
KeywordsCML / blastic crisis / chromosomal translocation / AML1 / EVI-1 / chimeric protein / differentiation suppression / growth stimulation / Evi-1 / 転座型白血病 / t(3;21)転座 / AML1 / EVI-1キメラ遺伝子 / 転写因子
Research Abstract

The t (3 ; 21) (q26 ; q22) translocation, which is one of consistent chromosomal abnormalities found in blastic crisis of chronic myelocytic leukemia (CML) , is thought to play an important role in leukemic progression of CML to an acute blastic crisis phase. The AML1 gene, which is located at the translocation breakpoint of the t (8 ; 21) (q22 ; q22) translocation found in acute myelocytic leukemia, was also rearranged by the t (3 ; 21) (q26 ; q22) translocation. Screening of a cDNA library of the t (3 ; 21) -carrying leukemic cell line cells (SKH1) resulted in the isolation of AML1/EVI-1 chimeric cDNAs. SKH1 cells expressed the 180 Kd AML1-EVI-1 fusion protein containing an amino-terminal half of AML1 including a runt homology domain which is fused to the entire of zinc finger EVI-1 protein. These findings strongly suggest that the t (3 ; 21) translocation results in the formation of a new class of a chimeric transcription factor which could contribute to leukemic progression of CML … More through interference with cell growth and differentiation. Biochemical analyzes revealed that AML1/EVI-1 itself does not alter the transactivation level through PEBP2 sites but dominantly suppresses the transactivation by intact AML1, which is assumed to be a stimulator of myeloid cell differentiation. The DNA-binding competition is a putative mechanism of such dominant negative effects of AML1/EVI-1 because it binds to PEBP2 sites in the higher affinity than AML1. Furthermore, AML1/EVI-1 stimulated the c-fos promoter transactivation and raised the AP-1 activity. Experiments, using deletion mutants of AML1/EVI-1, showed that these two functions are mutually independent because the dominant negative effects upon intact AML1 and the stimulation of AP-1 activity are dependent on the runt domain and the zinc finger domain near the C-terminus, respectively. Furthermore we showed that AML1/EVI-1 blocks granulocytic differentiation, otherwise induced by G-CSF,of 32Dc13 myeloid cells. It was also suggested that both AML1-derived and EVI-1-derived portions of the fusion protein play crucial roles for such differentiation block. We conclude that the leukemic cell transformation in t (3 ; 21) leukemias is probably caused by those dual functions of AML1/EVI-1 chimeric protein. Less

Report

(3 results)
  • 1994 Annual Research Report   Final Research Report Summary
  • 1993 Annual Research Report
  • Research Products

    (30 results)

All Other

All Publications (30 results)

  • [Publications] Mitani K: "Generation of the AML1/Evi-1 fusion gene in the t(3:21)(q26;q22)causes blastic crisis in chronic myelocytic leukemia." EMBO J.13. 504-510 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Tanaka T: "Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain." J.Biol.Chem.269. 24020-24026 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Ogawa S: "Homozygous loss of the cyclin-dependent kinase 4-inhibitor(p16)gene in human leukemias." Blood. 84. 2431-2435 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Tanaka T: "An acute myeloid leukemia gene,AML1,regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alter native spliced forms." EMBO J.14. 341-350 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Tanaka T: "Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t(3;21)leukemias." Mol.cell.Biol.(In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Mitani K: "Cloning of several spieces of MLL/MEN.chimeric cDNAs in myeloid leukemias with t(11;19)(g23;p13.1)translocation." Blood. (In press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] 平井久丸: "白血病の分子医学" 羊土社, 145 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] 平井久丸: "臨床分子生物学" 日本臨床社, 874 (1994)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Mitani K,OgawaS,Miyoshi H,Kurokawa M,Mano H,Yazaki Y,Ohki M,Hirai H: "Generation of the AML1/Evi-1 fusion gene in the t (3 ; 21) (q26 ; q22) causes blastic crisis in chronic myelocytic leukemia." EMBO J.13. 504-510 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Tanaka T,Nishida J,Mitani K,Yazaki Y,Hirai H.: "Evi-1 raises AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain." J.Biol.Chem.269. 24020-24026 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Ogawa S,Hirano N,Sato M,Takahashi T,Hangaishi A,Tanaka K,Kurokawa M,Tanaka T,Mitani K,Yazaki Y,Hirai H.: "Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias." Blood. 84. 2431-2435 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Mitani K,Sasaki K,Hayashi Y,Mano H,Yazaki Y,Hirai H.: "Molecular analysis of the t (1 ; 19) (q23 ; p13) translocation observed in adult leukemias." Int.J.Hematol.60. 267-271 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Tanaka T,Tanaka K,Ogawa S,Kurokawa M,Mitani K,Nishida J,Shibata Y,Yazaki Y,Hirai H.: "An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms." EMBO J.14. 341-350 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Harada H,Kondo T,Ogawa S,Tamura T,Kitagawa M,Tanaka N,Lamphier MS,Hirai H.: "Taniguchi T.Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia ; A possible mechanism of tumor suppressor inactivation." Oncogene. 9. 3313-3320 (1994)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Tanaka T,Mitani K,Kurokawa M,Ogawa S,Tanaka K,Nishida J,Yazaki Y,Shibata Y,Hirai H.: "Dual functions of the AML1/Evi-1 chimeric protein in the mechanism of leukemogenesis in t (3 ; 21) leukemias." Mol.Cell.Biol.(In press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Mitani K,Kanda Y,Ogawa S,Tanaka T,Inazawa J,Yazaki Y,Hirai H.: "Cloning of several spieces of MLL/MEN chimeric cDNAs in myeloid leukemias with t (11 ; 19) (q23 ; p13.1) translocation." Blood. (In press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1994 Final Research Report Summary
  • [Publications] Mitani K: "Generation of the AML1/Evi-1 fusion gene in the t(3:21)(q26;q22) causes blastic crisis in chronic myelocytic leukemia." EMBO J.13. 504-510 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Tanaka T: "Evi-1 raoses AP-1 activity and stimulates c-fos promoter transactivation with dependence on the second zinc finger domain." J.Biol.Chem. 269. 24020-24026 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Ogawa S: "Homozygous loss of the cyclin-dependent kinase4-inhibitor(p16) gene in human leukemias." Blood. 84. 2431-2435 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Tanaka T: "An acute myeloid leukemia gene,AML1,regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alter native spliced forms." EMBO J. 14. 341-350 (1995)

    • Related Report
      1994 Annual Research Report
  • [Publications] Tanaka T: "Dual functions of the AML1/Evi-1 chimericprotein in the mechanism of leukemogenesis in t(3;21) leukemias." Mol.Cell.Biol. (In press).

    • Related Report
      1994 Annual Research Report
  • [Publications] Mitani K: "Cloning of several spieces of MLL/MEN chimeric cDNAs in myeloid leukemias with t(11;19)(q23;p13.1) translocation." Blood. (In press).

    • Related Report
      1994 Annual Research Report
  • [Publications] 平井久丸: "白血病の分子医学" 羊土社, 145 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] 平井久丸: "臨床分子生物学" 日本臨床社, 874 (1994)

    • Related Report
      1994 Annual Research Report
  • [Publications] Toyoshima H: "Differently spliced cDNAs of human ltk receptor tyrosine kinase predict receptor proteins with and without tyrosine kinase domain and a soluble receptor protein." Proc.Natl.Acad.Sci.USA. 90. 5404-5408 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Sugimoto K: "Mutations of the p53 gene in myelodysplastic syndromes and MDS-derived leukemia." Blood. 81. 3022-3026 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Hanazono Y: "c-fps/fes protein-tyrosine kinase is implicated in a signaling pathway triggered by granulocyte-macrophage colony-stimulating factor and interleukin-3." EMBO J.12. 1641-1646 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Ogawa S: "Detection of the PML/RARα fusion gene in acute promyelocytic leukemia with a complex translocation involving chromosome 15,17,and 18." Cancer Genet.Cytogenet.69. 113-117 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Amano M: "Rearrangement of retinoic acid receptor α and PML in promyelocytic blast crisis of Ph1 chromosome positive chronic myelocytic leukemia with normal copies of chromosome 15." Blood. 81. 2469-2470 (1993)

    • Related Report
      1993 Annual Research Report
  • [Publications] Mitani K: "Generation of the AML1/Evi-1 fusion gene in the t(3;21)(q26;q22)causes blastic crisis in chronic myelocytic leukemia."

    • Related Report
      1993 Annual Research Report

URL: 

Published: 1993-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi